剥脱性点阵激光辅助光动力治疗雀斑样痣黑素瘤:前瞻性初步研究
这项非申办方前瞻性初步研究纳入10例组织学确诊的雀斑样痣黑素瘤(LM),采用剥脱性点阵激光(AFL)辅助5-氨基酮戊酸纳米乳(BF-200 ALA)光动力治疗(PDT),每2周一次共3次,光剂量90 J/cm²/次。末次PDT后4周行扩大切除并病理检查,完全组织学清除率为7/10(70%),光照疼痛可耐受,但治疗期间出现一些严重皮肤反应。结论为AFL辅助PDT对LM有中等疗效,因副作用仅应考虑用于无法手术者。
要点
- AFL辅助BF-200 ALA PDT治疗LM的完全组织学清除率为70%(7/10)。
- 光照期疼痛可耐受,视觉评估量表平均疼痛评分2.9–3.8。
- 治疗期间出现一些严重皮肤反应,因副作用仅建议用于无法手术的LM。
核心结论
- AFL辅助PDT对LM的组织学清除显示中等疗效,可能作为无法手术LM的替代治疗,但因副作用仅应考虑用于无法手术者。
研究设计与样本
- 非申办方前瞻性初步研究,纳入10例组织学确诊的LM,每2周行AFL辅助PDT共3次,光剂量90 J/cm²/次,局部麻醉用罗哌卡因。
主要发现
- 完全组织学清除率为7/10(70%)。
- 光照期疼痛可耐受,PDT各次视觉评估量表平均疼痛评分为2.9–3.8。
- 治疗期间出现一些严重皮肤反应。
关键数值与推荐
- 末次PDT后4周行扩大切除并送组织病理检查,以手术标本完全组织学清除LM为主要结局。
临床怎么用
- AFL辅助PDT可考虑作为无法手术LM的替代治疗,但需权衡治疗期间严重皮肤反应的风险。
局限性
- 本研究为非申办方前瞻性初步研究,样本量仅10例LM。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Lentigo maligna (LM) is an in situ form of melanoma carrying a risk of progression to invasive lentigo maligna melanoma (LMM). LM poses a clinical challenge, with subclinical extension and high recurrence rates after incomplete surgery. Alternative treatment methods have been investigated with varying results. Photodynamic therapy (PDT) with methylaminolaevulinate (MAL) has already proved promising in this respect. OBJECTIVES: To investigate the efficacy of ablative fractional laser (AFL)-assisted PDT with 5-aminolaevulinic acid nanoemulsion (BF-200 ALA) for treating LM. METHODS: In this non-sponsored prospective pilot study, ten histologically verified LMs were treated with AFL-assisted PDT three times at 2-week intervals using a light dose of 90 J/cm2 per treatment session. Local anaesthesia with ropivacaine was used. Four weeks after the last PDT treatment the lesions were treated surgically with a wide excision and sent for histopathological examination. The primary outcome was complete histopathological clearance of the LM from the surgical specimen. Patient-reported pain during illumination and the severity of the skin reaction after the PDT treatments were monitored as secondary outcomes. RESULTS: The complete histopathological clearance rate was 7 out of 10 LMs (70%). The pain during illumination was tolerable, with the mean pain scores for the PDT sessions on a visual assessment scale ranging from 2.9 to 3.8. Some severe skin reactions occurred during the treatment period, however. CONCLUSIONS: Ablative fractional laser-assisted PDT showed moderate efficacy in terms of histological clearance. It could constitute an alternative treatment for LM but due to the side effects it should only be considered in inoperable cases.
引用
- Räsänen JE, Neittaanmäki N, Jeskanen L, et al. Ablative fractional laser-assisted photodynamic therapy for lentigo maligna: a prospective pilot study. J Eur Acad Dermatol Venereol. 2019. PMID: 31465596. doi:10.1111/jdv.15925
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。